CRVS
Corvus Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$15.32
-0.69 ▼ -4.31%
🌙 3월 13일 7:46 PM ET (한국 3/14 08:46)
$15.17
-0.15 ▼ -0.98%
| Index | RUT | P/E | - | EPS (ttm) | -0.51 | Insider Own | 24.17% | Shs Outstand | 0.07B | Perf Week | -3.01% |
| Market Cap | 1.28B | Forward P/E | - | EPS next Y | -10.3% | Insider Trans | - | Shs Float | 0.06B | Perf Month | -22.39% |
| Enterprise Value | 1.23B | PEG | - | EPS next Q | -0.14 | Inst Own | 36.5% | Short Float | 25.2% | Perf Quarter | 80.45% |
| Income | -0.02B | P/S | - | EPS this Y | -250.38% | Inst Trans | 5.66% | Short Ratio | 4.5 | Perf Half Y | 152.81% |
| Sales | 0.00B | P/B | 18.7 | EPS next 5Y | - | ROA | -21.83% | Short Interest | 16.01M | Perf YTD | 98.96% |
| Book/sh | 0.82 | P/C | 22.61 | EPS past 3/5Y | 15.4% -21.44% | ROE | -32.6% | 52W High | -43.15% ($26.95) | Perf Year | 240.44% |
| Cash/sh | 0.68 | P/FCF | - | Sales past 3/5Y | - | ROIC | -24.75% | 52W Low | 503.15% ($2.54) | Perf 3Y | 2146.33% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 79.27% | Gross Margin | - | Volatility(W/M) | 7.7% 6.63% | Perf 5Y | 374.3% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.29 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 6.21 | EPS Q/Q | 16.2% | Profit Margin | - | RSI (14) | 39.99 | Recom | 1.14 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.21 | Sales Q/Q | - | SMA20 | -10.96% ($17.21) | Beta | 0.91 | Target Price | $35.17 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 3000000 | SMA50 | -5.58% ($16.23) | Rel Volume | 0.34 | Prev Close | $16.01 |
| Employees | 37 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | -15.92% - | SMA200 | 77.26% ($8.64) | Avg Volume(3M) | 3.56M | Price | $15.32 |
| IPO | 2016/3/23 | Option/Short | Yes/Yes | Trades | 12196 | Volume | 1,221,485 | Change | -4.31% |
뉴스 로딩 중...